Ensuring Sufficient Supply of Testing Act

Bill: 118-hr-3840
Sponsor: full_name: Rep. Dunn, Neal P. [R-FL-2]
Introduced: 2023-06-06
Policy area: Health
Subjects: Health technology, devices, supplies

Medical tests and diagnostic methods

Public contracts and procurement

Strategic materials and reserves
Latest action: action_date: 2023-06-09
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-06-06
action_desc: Introduced in House
text: <html><body><p><b>Ensuring Sufficient Supply of Testing Act</b></p> <p>This bill expressly authorizes the Department of Health and Human Services (HHS) to enter into certain contracts and cooperative agreements with clinical laboratories as part of maintaining the Strategic National Stockpile. The Strategic National Stockpile consists of drugs, vaccines, medical products, and other supplies that may be deployed to respond to bioterrorist attacks or other public health emergencies.</p> <p>Current law permits HHS to enter into specified types of contracts and cooperative agreements with vendors (e.g., manufacturers and distributors of medical products) for managing inventory of and ensuring production capacity for supplies needed for the stockpile. The bill specifies that clinical laboratories may participate as vendors in those types of contracts and agreements.</p></body></html>

tv_txt: I 118th CONGRESS 1st Session H. R. 3840 IN THE HOUSE OF REPRESENTATIVES June 6, 2023 Mr. Dunn of Florida (for himself and Mrs. Dingell ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to authorize certain contracts and cooperative agreements with clinical laboratories for purposes of delivery of medical products to the Strategic National Stockpile.

1. Short title This Act may be cited as the Ensuring Sufficient Supply of Testing Act . 2. Contracts and cooperative agreements with clinical laboratories for the Strategic National Stockpile Section 319F–2(a)(5)(A) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(5)(A)) is amended by inserting after contracts or cooperative agreements with vendors, which may include manufacturers or distributors of medical products, the following: as well as clinical laboratories, .